Among the selected genes (Figure 2), HLA-DRA, HLA-DRB1, OAS1, and CD74 had concordant prognostic indications at the mRNA and protein expression levels in bulk NSCLC tumors with stage I, II, or IIIA (Figure 3). Here, HLA-DRA is linked to non-small cell lung carcinoma.